CamilaMasiasMD

PubMed

• When you think you should transfuse…don't!
  Nancy Benitez, Claribel Resto, Richard R Gammon, Harold Alvarez, Camila Masias> ;Laboratory Medicine. 2024 Apr 6
• A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.
  Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, Shruti Chaturvedi, Ana G Antun, Andrew M Farland, Ryan Woods, Ara Metjian, Yara A Park, Gustaaf de Ridder, B...> ;Research and Practice in Thrombosis and Haemostasis. 2024 Mar 1
• A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.
  Abou-Ismail, M., Zheng, X., Woods, R., Mouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, Shruti Chaturvedi, Ana G Antun, Andrew M Farland, Ryan Woods, Ara Met...> ;Blood Advances. 2024 Feb 13
• Should older patients with low weight and CKD receive full-dose DOACs for treatment of acute proximal DVT?
  Gallastegui, N., Masias, C.> ;Hematology. American Society of Hematology. Education Program. 2023 Dec 8
• 1 citations
  Five years of caplacizumab - lessons learned and remaining controversies in immune-mediated thrombotic thrombocytopenic purpura.
  Linus Alexander Völker, Paul Thomas Brinkkoetter, Spero R Cataland, Camila Masias> ;Journal of Thrombosis and Haemostasis. 2023 Oct 1
• The impact of TTP in the brain.
  Camila Masias> ;Blood. 2023 Jul 27
• 1 citations
  Use of patient-reported outcome measures in patients with venous thromboembolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables i...
  Cindy M M de Jong, Kerstin de Wit, Stephen A Black, Adam M Gwozdz, Camila Masias, Anna L Parks, Helia Robert-Ebadi, Rosa Talerico, Scott C Woller, Frederikus A Klok> ;Journal of Thrombosis and Haemostasis. 2023 Oct 1
• 11 citations
  Race, rituximab, and relapse in TTP.
  Shruti Chaturvedi, Ana G Antun, Andrew M Farland, Ryan Woods, Ara Metjian, Yara A Park, Gustaaf de Ridder, Briana Gibson, Raj S Kasthuri, Darla K Liles, Frank Akwaa, T...> ;Blood. 2022 Sep 22
• 8 citations
  Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Di...
  Paul L den Exter, Scott C Woller, Helia Robert-Ebadi, Camila Masias, Pierre-Emmanuel Morange, David Castelli, John-Bjarne Hansen, Geert-Jan Geersing, Deborah M Siegal,...> ;Journal of Thrombosis and Haemostasis. 2022 Aug 1
• 2 citations
  A systematic review of biomarkers among hospitalized patients with COVID-19 predictive of venous thromboembolism: A communication from the Predictive and Diagnostic Va...
  Scott C Woller, Kerstin de Wit, Helia Robert-Ebadi, Camila Masias, Frederikus A Klok, Paul L den Exter, Pierre-Emmanuel Morange, David Castelli, John-Bjarne Hansen> ;Research and Practice in Thrombosis and Haemostasis. 2022 Aug 1
• 4 citations
  Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune-mediated trhrombotic thrombocytopenic purpura.
  Haiwa Wu, Lauren Jay, Shili Lin, Chenggong Han, Shangbin Yang, Spero R. Cataland, Camila Masias> ;British Journal of Haematology. 2020 Feb 17
• 27 citations
  How targeted therapy disrupts the treatment paradigm for acquired TTP: the risks, benefits, and unknowns
  Marshall A. Mazepa, Camila Masias, Shruti Chaturvedi> ;Blood. 2019 Aug 1
• 39 citations
  The Role of ADAMTS13 Testing in the Diagnosis and Management of Thrombotic Microangiopathies and Thrombosis
  Camila Masias, Spero R. Cataland> ;Blood. 2018 Aug 30
• 8 citations
  No major differences in outcomes between the initial and relapse episodes in patients with thrombotic thrombocytopenic purpura: The experience from the Ohio State Univ...
  Camila Masias, Haiwa Wu, Michael McGookey, Lauren Jay, Spero R. Cataland, Shangbin Yang> ;American Journal of Hematology. 2018 Mar 1
• 21 citations
  Novel therapies in thrombotic thrombocytopenic purpura
  Camila Masias, Spero R. Cataland> ;Research and Practice in Thrombosis and Haemostasis. 2018 Jan 1
• 51 citations
  Cyclosporine or steroids as an adjunct to plasma exchange in the treatment of immune-mediated thrombotic thrombocytopenic purpura
  Spero R. Cataland, Peter J. Kourlas, Shangbin Yang, Susan Geyer, Leslie Witkoff, Haiwa Wu, Camila Masias, James N. George, Haifeng M. Wu> ;Blood Advances. 2017 Oct 24
• 58 citations
  None of the above: thrombotic microangiopathy beyond TTP and HUS
  Camila Masias, Sumithira Vasu, Spero R. Cataland> ;Blood. 2017 May 25
• Join now to see all

Journal Articles

• The Role of ADAMTS13 Testing in the Diagnosis and Management of Thrombotic Microangiopathies and Thrombosis  
  Spero R Cataland, Camila Masias, Blood

Abstracts/Posters

• Severely Deficient ADAMTS13 Activity Predicts Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Pregnancy
  Camila Masias, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

• A Pilot Study on Biomarkers of Vascular Injury in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura 
  61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019